SATB1 has been closely linked to the progression of esophageal cancer, particularly esophageal squamous cell carcinoma (ESCC), the most common form of esophageal cancer, arising primarily from abnormal squamous epithelial cell proliferation (161). Here, SATB1 is linked to esophageal squamous cell carcinoma.